A Randomised Control Clinical Trial Investigating the Effect of H-PRF on Implant Stability and Marginal Bone Levels

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 17, 2024

Primary Completion Date

June 1, 2026

Study Completion Date

September 1, 2026

Conditions
Osseointegration Failure of Dental Implant
Interventions
BIOLOGICAL

Horizontal platelet-rich fibrin (H-PRF)

Most commercially available centrifuges used for PRF production are fixed-angle systems designed primarily for pelleting samples to the bottom of tubes and are not particularly efficient at separating the cell layers effectively. Research has demonstrated that PRF produced using horizontal centrifugation (H-PRF) can lead to a higher concentration of platelets and leukocytes compared to PRF produced from fixed-angle centrifugation (LPRF). The resulting PRF from horizontal centrifugation is termed 'horizontal platelet-rich fibrin' (H-PRF). The H-PRF clot will be produced using a Bio-PRF horizontal centrifuge machine. This machine is CE marked and regularly used in the Dublin Dental University Hospital.

Trial Locations (1)

D02 F859

RECRUITING

Dublin Dental University Hospital, Dublin

All Listed Sponsors
lead

University of Dublin, Trinity College

OTHER